"This is the best use of my time to remain current with what is going on in the industry."
Congratulations to the eCOA Best Practices team for publishing their paper “Best Practice Recommendations for Electronic Clinical Outcome Assessment Data Changes”
in the peer-reviewed SCDM Journal “Digital First”.
Delong | | Journal of the Society for Clinical Data Management (jscdm.org)
This is a significant work done by the joint team of eClinical Forum and C-Path PRO Consortium and C-Path eCOA Consortium, and comprises their discussions over many years, outlining best practices and guidelines on changes to eCOA data, aligned to latest health authority guidance, and based on expertise from all three organizations.
The team provided a public webinar for Feb 6, 2024 at UTC -0500 (0700 PST, 1000 EST, 1400 CET).
This team has now sunset.
eCF Webinar on RBQM, ATRA, and Fit-for-Purpose Data
Log in to your eCF website account to see more:
RBQM is now a requirement under ICH E6(R3). But how does it fit with other data review activities?
The webinar is available to all our members. Date and Time: Wednesday, 25 February 2026, 14:00 UTC.
eCF Views & News
We send out a brief monthly newsletter via email to all our active eCF members to keep them abreast of the activities of eCF that they can participate in. The more who participate, the better we are "A Network Powered by Peers". Click to see the most current newsletter.
eCF Public Webinar March: Turning the ATRA Position Paper into Practice
This webinar focuses on practical implementations of the eCF industry position paper "Strategies for implementing Audit Trail Review"
The webinar is available to all our members as well as the general public. Date and Time: Thursday, 19 March 2026, 9:00 am EDT / 1:00 pm UTC. Sign up here
eCF Spring 2026 Workshops Announced!
We are happy to announce our Spring workshops!
Europe/Hybrid: Hosted by Servier outside of Paris on April 14-16 (this will be livestreamed as well)
Americas: Hosted by YPrime outside of Philadelphia, PA on April 28-30
Asia: Hosted by Novartis in Tokyo, Japan on April 2-3